Literature DB >> 30336804

A polypharmacy risk prediction model for elderly patients based on sociodemographic and clinical factors.

María Isabel Santos-Pérez, Inmaculada Fierro, M Esther Salgueiro-Vázquez, María Del Mar Gallardo-Lavado, María Sáinz-Gil, Luis H Martín-Arias.   

Abstract

OBJECTIVE: Elderly people take increasing amounts of medication. The aim of our study was to determine the effects of different sociodemographic and clinical factors on polypharmacy and to develop a risk prediction model in outpatients aged 65 years and older.
MATERIALS AND METHODS: Cross-sectional, observational, descriptive study of outpatients aged 65 years and older scheduled for a specialist visit. Data on sociodemographic (age, sex, place of residence, and institutionalization) as well as on clinical variables (number of prescribing physicians and number of diagnoses) were collected. Polypharmacy was defined as the uninterrupted use of more than 5 medications within the last 3 months. To determine the risk factors for polypharmacy among these patients, a multivariate logistic regression model was developed and subsequently validated using bootstrap resampling techniques. The model was assessed for its discrimination accuracy using the area under the curve (ROC AUC).
RESULTS: A total of 225 outpatients were included for development of the model. Polypharmacy was found in 46.7% of patients. The determinants that best predicted polypharmacy included: age, institutionalization, number of prescribing physicians, and number of diagnoses. The ROC AUC was 0.85.
CONCLUSION: The predictive model developed in this study, which consists of 4 readily obtainable variables, may be a useful tool for identifying and monitoring elderly patients at risk for polypharmacy.
.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30336804     DOI: 10.5414/CP203238

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  2 in total

Review 1.  A cross-sectional study of psychotropic drug use in the elderly: Consuming patterns, risk factors and potentially inappropriate use.

Authors:  María Isabel Santos-Pérez; Inmaculada Fierro; M Esther Salgueiro-Vázquez; María Sáinz-Gil; Luis H Martín-Arias
Journal:  Eur J Hosp Pharm       Date:  2019-06-11

2.  Number of consulting medical institutions and risk of polypharmacy in community-dwelling older people under a healthcare system with free access: a cross-sectional study in Japan.

Authors:  Toshiki Suzuki; Masao Iwagami; Shota Hamada; Tomoyuki Matsuda; Nanako Tamiya
Journal:  BMC Health Serv Res       Date:  2020-04-26       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.